Sustainability Leaders Excelya’s EcoVadis Bronze Medal and top 35% company recognition signal a strong sustainability and responsible business posture, presenting a selling point for pharma clients prioritizing ESG compliance and responsible outsourcing partners.

Global CRO Footprint With operations spanning 28 countries and a global expert base, Excelya can offer multinational trial support, enabling seamless cross-border studies and faster site activation for sponsors expanding into Europe, the US, and India.

Therapeutic Focus Specialization in Oncology, Rare Disease, Infectious Disease, Immunology, CNS, and Late Phase & Real World Evidence provides targeted opportunities to pair Excelya with sponsors in high-growth therapeutic areas seeking full-service CRO, FSP, and resourcing solutions.

Financial Stability Revenue in the upper mid-range ($100M-$250M) paired with established leadership and ongoing recognition supports credibility when engaging risk-averse clients looking for dependable CRO partners with scalable capabilities.

Tech-Driven Delivery Adopting a modern tech stack (Tableau, AWS, BigQuery, Azure, GitLab, DocuSign, DBT, SQL) enables data-driven trial management and streamlined operations, offering a compelling case to clients seeking integrated data and process efficiencies.